179 related articles for article (PubMed ID: 19200746)
1. ApoM: gene regulation and effects on HDL metabolism.
Nielsen LB; Christoffersen C; Ahnström J; Dahlbäck B
Trends Endocrinol Metab; 2009 Mar; 20(2):66-71. PubMed ID: 19200746
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein M: progress in understanding its regulation and metabolic functions.
Christoffersen C; Dahlbäck B; Nielsen LB
Scand J Clin Lab Invest; 2006; 66(7):631-7. PubMed ID: 17101555
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C; Poy MN; Stoffel M
Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.
Huang XS; Zhao SP; Hu M; Luo YP
Med Hypotheses; 2007; 69(1):136-40. PubMed ID: 17218068
[TBL] [Abstract][Full Text] [Related]
6. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein M--a novel player in high-density lipoprotein metabolism and atherosclerosis.
Dahlbäck B; Nielsen LB
Curr Opin Lipidol; 2006 Jun; 17(3):291-5. PubMed ID: 16680035
[TBL] [Abstract][Full Text] [Related]
9. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
[TBL] [Abstract][Full Text] [Related]
10. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
11. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
Xu N; Nilsson-Ehle P; Ahrén B
Biochem Biophys Res Commun; 2006 Apr; 342(4):1174-7. PubMed ID: 16516154
[TBL] [Abstract][Full Text] [Related]
12. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB
J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500
[TBL] [Abstract][Full Text] [Related]
13. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.
Dullaart RP; Plomgaard P; de Vries R; Dahlbäck B; Nielsen LB
Clin Chim Acta; 2009 Aug; 406(1-2):129-33. PubMed ID: 19539616
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?
Dahlbäck B; Nielsen LB
Cell Mol Life Sci; 2009 Feb; 66(4):559-64. PubMed ID: 19153651
[TBL] [Abstract][Full Text] [Related]
15. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
Wei J; Shi Y; Zhang X; Feng Y; Luo G; Zhang J; Mu Q; Tang Y; Yu Y; Pan L; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
[TBL] [Abstract][Full Text] [Related]
16. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.
Sevvana M; Ahnström J; Egerer-Sieber C; Lange HA; Dahlbäck B; Muller YA
J Mol Biol; 2009 Nov; 393(4):920-36. PubMed ID: 19733574
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
Elsøe S; Christoffersen C; Luchoomun J; Turner S; Nielsen LB
Biochim Biophys Acta; 2013 Jul; 1831(7):1287-92. PubMed ID: 24046869
[TBL] [Abstract][Full Text] [Related]
18. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein M: bridging HDL and endothelial function.
Christoffersen C; Nielsen LB
Curr Opin Lipidol; 2013 Aug; 24(4):295-300. PubMed ID: 23652568
[TBL] [Abstract][Full Text] [Related]
20. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
Christoffersen C; Ahnström J; Axler O; Christensen EI; Dahlbäck B; Nielsen LB
J Biol Chem; 2008 Jul; 283(27):18765-72. PubMed ID: 18460466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
